Induction of Immune Mediators in Glioma and Prostate Cancer Cells by Non-Lethal Photodynamic Therapy
Author Information
Author(s): Kammerer Robert, Buchner Alexander, Palluch Patrick, Pongratz Thomas, Oboukhovskij Konstantin, Beyer Wolfgang, Johansson Ann, Stepp Herbert, Baumgartner Reinhold, Zimmermann Wolfgang
Primary Institution: Institute of Immunology, Friedrich Loeffler Institute, Tübingen, Germany
Hypothesis
Does non-lethal photodynamic therapy (PDT) induce immune responses in glioma and prostate cancer cells?
Conclusion
Non-lethal PDT can support anti-tumor immune responses but may also stimulate tumor growth-promoting pathways.
Supporting Evidence
- Non-lethal PDT significantly upregulated immune-related genes in cancer cells.
- Chemokine genes CXCL2, CXCL3, and IL6 were among the most upregulated after PDT.
- Early response genes were activated shortly after PDT treatment.
- Similar immune responses were observed in both glioma and prostate cancer cell lines.
Takeaway
This study shows that a special light treatment can help the body's immune system fight cancer, but it might also make some tumors grow faster.
Methodology
The study evaluated changes in gene expression in various cancer cell lines after non-lethal PDT using microarray analyses.
Potential Biases
Potential bias in interpreting the effects of PDT on tumor growth due to the complexity of tumor microenvironments.
Limitations
The study does not clarify whether the observed immune responses are beneficial or detrimental to tumor progression.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website